Isaac Health is a scalable platform for brain health and dementia care that partners with health systems to provide virtual screening, assessment, treatment and care management for people living with dementia and their family caregivers. The company’s telehealth model has driven 73% of patients to show improved neurocognitive function over six months, with 92% improving against cognitive goals within three weeks. Isaac Health raised $10.5 million in a Series A round led by Flare Capital Partners and has expanded through partnerships with New York City-based NYU Langone Health and Eli Lilly’s LillyDirect platform. The company earned the Joint Commission’s “Gold Seal of Approval” in both 2024 and 2025 and was named to the “New York Digital Health 100.”
